drugset / Trial / NCT03448211
A Study of PTS for Patients With Solid Tumors
SequentialOpen-labelTreatment
Summary
The primary objective of this study is to determine the MTD of PTS following local and intratumoral injections over a treatment course of two 5-day cycles to patients with palpable advanced solid malignancies who have failed standard treatment.
Timeline
- Start
- 2018-05-01
- Primary completion
- 2019-05-01
- Completion
- 2019-08-01
Outcome
Outcome not reported
Stopped (Business): “Development strategy reasons”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | P-TOLUENESULFONAMIDE | Small molecule | 660 mg | Other |
| Subject | P-TOLUENESULFONAMIDE | Small molecule | 1220 mg | Other |
| Subject | P-TOLUENESULFONAMIDE | Small molecule | 1880 mg | Other |
| Subject | P-TOLUENESULFONAMIDE | Small molecule | 2440 mg | Other |